Using our anti-MPO GN model where disease is mediated by active autoimmunity to MPO, we gave a single dose of vec-DNase I or vec-GFP 10 days after the establishment of anti-MPO autoimmunity (Figure 9A). This evidence concerns the gene DNASE1 and ganglioneuroma.